Elephas Biosciences

Home | Elephas | Elephas Platform

Madison, United States · Founded 2020 · $136.5M raised

Headquarters
Madison, Wisconsin
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$136.5M
Last Round
$40.0M Extension RoundNov 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Elephas Biosciences is a privately held precision oncology company based in Madison, Wisconsin, developing the elive™ platform — an ex vivo system that profiles live tumor biopsies to predict immunotherapy response. Founded in 2020, the company preserves native tumor microenvironments from core needle biopsies to enable real-time immune characterization, helping pharmaceutical and clinical partners improve cancer treatment selection.

Summary

Elephas Biosciences is a Biotech company based in Madison, United States, founded in 2020. It has raised $136.5M in total across 5 rounds, most recently a $40.0M Extension Round in Nov 2025. Investors include Northpond Ventures, ARCH Venture Partners and State of Wisconsin Investment Board.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundNov 2025
$40.0M

Sign up to see all 5 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elephas Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/elephas-biosciences"><img src="https://indexed.vc/api/badge/company/elephas-biosciences" alt="Elephas Biosciences on Indexed.vc" width="260" height="76" /></a>